Diagnosis of Cardiac Amyloidosis in South Asia: Need for a Collaborative Approach from Researchers and Clinicians.

Recent developments in diagnostic approaches for cardiac amyloidosis (CA) have augmented the possibility of its accurate diagnosis. Rising cardiovascular diseases in South Asian countries along with many undiagnosed cases make it important for cardiologists to screen patients for CA. Besides, the increasing susceptibility of amyloidosis patients to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection needs prompt diagnosis and management of CA in the COVID-19 era. With this focus in mind, a review of recent diagnostic approaches and treatment options adapted for CA is outlined in this article. In addition, a layout of different initiatives to diagnose such patients in the future has also been depicted. These approaches, if collaboratively adopted by the researchers and clinicians, would aid in the accurate diagnosis of CA patients in the South Asian population including India.